infants
New ACIP Panel Votes to Recommend Clesrovimab, Second Antibody to Prevent RSV in Infants
The seven newly appointed members of ACIP voted 5-to-2 to recommend Enflonsia, the second long-acting monoclonal ...
JUNE 26, 2025
FDA Approves Enflonsia, Second RSV Antibody for Infants
The FDA has approved the second monoclonal antibody for the prevention of RSV in neonates and infants, ...
JUNE 10, 2025
Infant RSV Hospitalization Rates Dropped Significantly After Antibody, Vaccine Prevention Introduced
RSV-associated hospitalization in infants fell sharply during the first virus season after the introduction of ...
JUNE 5, 2025
Beyfortus Approved to Prevent RSV in Infants & Children
The FDA approved Beyfortus (for the prevention of RSV lower respiratory tract disease in newborns and infants born ...
JULY 17, 2023
ACIP Recommends PREVNAR 20 for Infants and Children
The CDC’s ACIP recently voted to recommend the 20-valent Pneumococcal Conjugate Vaccine for routine use to ...
JULY 17, 2023
FDA Advisory Committee Supports Nirsevimab to Prevent RSV in Infants
The FDA Antimicrobial Drugs Advisory Committee endorsed the safety and efficacy of an experimental ...
JUNE 9, 2023
Higher COVID-19 Hospitalization Rates Seen Among Infants
Although still relatively low, rates of hospitalizations from COVID-19 in infants younger than 6 months old are ...
NOVEMBER 28, 2022
Breastfeeding, Preterm Birth Predict Infant C. difficile Carrier Status
Preemies and those who are not breastfed are more likely to carry toxigenic Clostridioides difficile during their ...
FEBRUARY 11, 2022
FDA Approves Fluzone Quadrivalent for Infants and Toddlers
The FDA expanded the use of the 0.5 mL vaccine for children from 6 to 35 months of age.
JANUARY 23, 2019
Hand-Washing Not a Panacea Against MRSA Transmission in NICU
During an average nine-day NICU stay, an infant is likely to have about 250 contacts with health care workers who ...
JULY 7, 2017
